https://pubmed.ncbi.nlm.nih.gov/34656144/
A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of...
The high-dose group demonstrated a statistically significant improvement in the primary endpoint and a good safety profile. Overall, high-dose PXT3003 is a...
double blind